Regorafenib Dose Optimization Study (ReDOS): Randomized phase II trial to evaluate escalating dosing strategy and pre-emptive topical steroids for Regorafenib in refractory metastatic colorectal cancer (mCRC) - An ACCRU Network study Meeting Abstract
| Authors: | Bekaii-Saab, T.; Ou, F.; Anderson, D.; Ahn, D.; Boland, P.; Ciombor, K.; Jacobs, N.; Desnoyers, R.; Cleary, J.; Meyers, J.; Chiorean, E.; Pedersen, K.; Barzi, A.; Sloan, J.; McCune, J.; Lacouture, M.; Lenz, H.; Grothey, A. |
| Abstract Title: | Regorafenib Dose Optimization Study (ReDOS): Randomized phase II trial to evaluate escalating dosing strategy and pre-emptive topical steroids for Regorafenib in refractory metastatic colorectal cancer (mCRC) - An ACCRU Network study |
| Meeting Title: | ESMO 20th World Congress on Gastrointestinal Cancer |
| Journal Title: | Annals of Oncology |
| Volume: | 29 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2018 Jun 20-23 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2018-06-01 |
| Start Page: | v105 |
| Language: | English |
| ACCESSION: | WOS:000439970900014 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdy149.013 |
| Notes: | Meeting Abstract: O-014 -- Source: Wos |
